Expert Adviser:

As a Ph.D. molecular biologist with expertise in medical communications, Kristen is able to meet her clients’ needs for depth, breadth, and accuracy in Non-Small Cell Lung Cancer. Through the ONCrg Advisory services, you can contact Kristen directly for personalized answers to non-proprietary questions, targeted analyses, and custom insights in Non-Small Cell Lung Cancer.   More

NSCLC Oncology Resources

Medical Conference Coverage:

ONCrg Conference covers the entire NSCLC landscape and delivers expert analysis of noteworthy scientific, clinical, and commercial changes at major medical conferences. NSCLC is the leading cause of cancer death worldwide, but the treatment landscape is evolving rapidly, and a diverse array of agents are in development.   More

Competitive Landscape Analysis:

Although chemotherapy still forms the backbone of treatment in the majority of NSCLC cases, immunotherapies and targeted treatments are shifting the standard of care. Quarterly, ONCrg Pipeline Strategies delivers cutting edge profiles across the entire competitive landscape, providing valuable analytics by class and treatment subset for new drugs in Phase I/II development and beyond.   More

Monthly Surveillance Reports:

In 2015, the FDA approved more therapies in NSCLC than for any other oncology indication. ONCrg Sentinel provides vigilant monitoring of rapidly evolving scientific, clinical, and commercial activities in oncology. ONCrg experts deliver incisive commentaries on current news events to inform subscribers each month, preparing them to respond wisely to ever-changing market conditions.   More